Clinical studies recruiting near Albuquerque

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · R1 Therapeutics Clinical Trial Site · R1 Therapeutics · NCT06712654 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · University of New Mexico · Novartis Pharmaceuticals · NCT05755386 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · New Mexico Oncology Hematology Consultants Ltd. ( Site 0090) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of New Mexico Cancer Center · National Cancer Institute (NCI) · NCT05564390 Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
NA · University of New Mexico Center for Brain Recovery and Repai · University of New Mexico · NCT04432883 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · University of New Mexico Cancer Center · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Albuquerque Clinical Trials · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of New Mexico Cancer Center · NRG Oncology · NCT05624996 Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
NA · UNM Psychology Clinic · University of New Mexico · NCT05489068 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · The Sleep Spot - Maimonides · Eli Lilly and Company · NCT07369011 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · University of New Mexico Cancer Center · Children's Oncology Group · NCT04322318 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0302 · Celgene · NCT05519085 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · University of New Mexico Cancer Center · NRG Oncology · NCT05946213 Molecular Genetics Studies of Cancer Patients and Their Relatives
Phase N/A · Lovelace Medical Center-Downtown · City of Hope Medical Center · NCT04185935 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · University of New Mexico Health Science Center · Duke University · NCT04278404 Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Phase 3 · University of New Mexico · Philip Spinella · NCT06070350 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · UNM Health Science Center · Boehringer Ingelheim · NCT06531824 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · University of New Mexico Cancer Center · NRG Oncology · NCT06532279 A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · University of New Mexico Health Sciences Center · Pfizer · NCT07029828 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · University of New Mexico Cancer Center · NRG Oncology · NCT05174169 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · University of New Mexico Hospital · SAb Biotherapeutics, Inc. · NCT07187531 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · University of New Mexico Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632327 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · University of New Mexico · Kura Oncology, Inc. · NCT07007312 Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
Phase 2 · University of New Mexico Health Sciences Center · University of New Mexico · NCT03908736 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · Presbyterian Kaseman Hospital (site 208) · VM Oncology, LLC · NCT03556228 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Renal Medicine Associates - Frenova F1 · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · University of New Mexico Cancer Center · Alliance for Clinical Trials in Oncology · NCT06876714 Pan Tumor Rollover Study
Phase 2 · Local Institution · Bristol-Myers Squibb · NCT03899155 Continued Pressure for Alveolar Protection (CPAP Trial)
NA · University of New Mexico · NICHD Neonatal Research Network · NCT07417111 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · University Of New Mexico School Of Medicine- Site Number : 8 · Sanofi · NCT07290803

Look up another city

Look up another condition